More on TNGX

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+100.0% Growth)
- Ratings (9.2 Score)

Upcoming Events

- Earnings (8/5/26 *Est.)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Tango Therapeutics, Inc (NQ:TNGX)
Delayed: 16.95 +0.12 (0.71%)
Prev. Close $16.83  
Open$16.73 
52 Wk High$ 
52 Wk Low$ 
Day High$17.63 
Day Low$16.00 
P/E N/A  
EPS$ 
Volume8,098,231 

Friends, Peers and Foes (?): RVMD, TEVA, ABBV, BNTX, GSK (more...)

Mar 6, 2026 05:33 PM Tango Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Mar 6, 2026 06:56 AM Tango Therapeutics Inc. (TNGX) PT Raised to $20 at Guggenheim
Mar 5, 2026 04:53 PM Form 144 Tango Therapeutics, Inc. Filed by: Crystal Adam
Mar 5, 2026 04:46 PM Tango Therapeutics Inc. (TNGX) PT Raised to $18 at Jefferies
Mar 5, 2026 10:30 AM Stifel Reiterates Buy Rating on Tango Therapeutics Inc. (TNGX) following Q4 results
Mar 5, 2026 07:37 AM Tango Therapeutics, Inc. (TNGX) Tops Q4 EPS by 3c
Mar 5, 2026 07:31 AM Form S-8 Tango Therapeutics, Inc.
Mar 5, 2026 07:15 AM Form 8-K Tango Therapeutics, Inc. For: Mar 05
Mar 5, 2026 07:11 AM Form 10-K Tango Therapeutics, Inc. For: Dec 31
Mar 5, 2026 07:00 AM Tango Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Highlights
View All Articles

Entities mentioned with TNGX

View All Entities